XOMA Key Stats
| Income Statement | |
| Revenue TTM | 33.78M |
| Revenue Quarterly YoY Growth | -24.93% |
| EPS Diluted TTM | -1.290 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -71.06M |
| Profitability | |
| Gross Profit Margin Quarterly | 99.55% |
| Profit Margin Quarterly | 32.01% |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 346.32M |
| Enterprise Value | 300.38M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 16.13 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 1.912 |
| Free Cash Flow | -11.74M |
| Return on Equity | -898.4% |
XOMA News
- 3 Humongous Health-Care Stocks This Week Fool May 11
- XOMA Management Presents at Credit Suisse 2013 Antibody Day (Transcript) Seeking Alpha May 10
- Positive Data on Celgene's Apremilast May 9
- ARNA Sheds Light on Belviq Launch May 9
- XOMA price target raised to $6 from $5 at Ladenburg May 9
- Positive Data on Celgene's Apremilast - Analyst Blog Zacks May 9
- ARNA Sheds Light on Belviq Launch - Analyst Blog Zacks May 9
- UPDATE: Canaccord Genuity Upgrades XOMA to Buy on Increased Confidence Benzinga May 9
- Stock Upgrades: Green Mountain Scales the Summit May 9
- VIVUS Reports Wider Loss May 9
XOMA Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). XOMA is up 76.37% over the last year vs S&P 500 Total Return up 31.95%, Athersys up 36.76%, and Agenus down 26.61%.
XOMA Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these XOMA related companies
Pro Ratings for XOMA
Pro Report PDF for XOMA
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download XOMA Pro Report PDF
Pro Strategies Featuring XOMA
Did XOMA make it into our Pro Portfolio Strategies?
XOMA Profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Other XOMA Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| XOMA | 4.18 | +0.02 | +0.48% | 346.32M |
